BRIDGEWATER, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting ...
BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (“Hillstream”, the “Company”) today announced the expansion of its collaboration with Minotaur Therapeutics, Inc.
Researchers have reconstructed the ancestral relationships of the hillstream loach family tree, detailing for the first time a range of pelvic adaptations that allow some members of the fish family to ...
-Evidence implicates ferroptosis, an emerging iron-mediated cell death, as a pathway to effectively eradicate uveal melanoma in proof-of-concept animal models -HSB-1216, a novel ferroptosis inducer ...
BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (HILS) (“Hillstream”, the “Company”) today announced the expansion of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback